K2M Enhances 3D-Printed Spine Portfolio Following FDA Clearance Of Two CASCADIA™ Interbody Systems Featuring Lamellar 3D Titanium Technology™

K2M Group Holdings, Inc.(NASDAQ:KTWO) (the "Company" or "K2M"), a global medical device company focused on designing, developing and commercializing innovative and proprietary complex spine and minimally invasive spine technologies and techniques, today announced it has received 510(k) clearances from the U.S. Food and Drug Administration (FDA) to market theCASCADIA™Cervicaland theCASCADIA AN Lordotic ObliqueInterbody Systems featuringLamellar 3D Titanium Technology™, the Company's innovative technology that uses 3D printing with the goal of allowing for bony integration throughout an implant.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news